TNFSF13 and autoimmune disease: Although dual inhibtion of BAFF and APRIL seems to have beneficial effects in some autoimmune disorder, in multiple sclerosis a trial for atacicept had to be halted due to increased disease activity in patients compared to placebo (268–270).